NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet-Reference-Cited by-同舟云学术

NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet

Published:2017-05-13 Issue:5 Volume:9 Page:492
ISSN:2072-6643
Container-title:Nutrients
language:en
Short-container-title:Nutrients

Author:

Amato Antonella,Caldara Gaetano-Felice,Nuzzo Domenico^ORCID,Baldassano Sara,Picone Pasquale,Rizzo Manfredi,Mulè Flavia,Di Carlo Marta

Publisher

MDPI AG

Subject

Food Science,Nutrition and Dietetics

Link

http://www.mdpi.com/2072-6643/9/5/492/pdf

Reference42 articles.

1. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders

2. Benefits of lifestyle modification in NAFLD

3. Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment

4. An Increased Circulating Angiotensin II Concentration is Associated with Hypoadiponectinemia and Postprandial Hyperglycemia in Men with Nonalcoholic Fatty Liver Disease

5. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Chinese medicine and plant-derived natural products in regulating triglyceride metabolism: Mechanisms and therapeutic potential;Pharmacological Research;2024-10

2. Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial;Medicina;2024-08-21

3. Dramatic Suppression of Lipogenesis and No Increase in Beta-Oxidation Gene Expression Are among the Key Effects of Bergamot Flavonoids in Fatty Liver Disease;Antioxidants;2024-06-25

4. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review;Metabolites;2024-06-20

5. Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies;Frontiers in Nutrition;2024-03-19